Denervation and β2-adrenoceptor-agonist administration on craniofacial bone density

Fitzpatrick Brendan; Woods Michael; Lynch Gordon; Manton David

doi:10.2478/aoj-2014-0004

Australasian Orthodontic Journal (May 2014)

Denervation and β2-adrenoceptor-agonist administration on craniofacial bone density

Fitzpatrick Brendan,
Woods Michael,
Lynch Gordon,
Manton David

Affiliations

Fitzpatrick Brendan: 1Graduate Orthodontics, University of Melbourne, Melbourne, Australia
Woods Michael: 2Oral and Maxillofacial Surgery, Royal Melbourne Hospital, Melbourne, Australia
Lynch Gordon: 3Department of Physiology, University of Melbourne, Melbourne, Australia
Manton David: 4Paediatric Dentistry, University of Melbourne, Melbourne, Australia

DOI: https://doi.org/10.2478/aoj-2014-0004
Journal volume & issue: Vol. 30, no. 1
pp. 32 – 38

Abstract

Read online

Objective: β2-agonist medications are thought to have adverse effects on bone density. Surgical denervation and intramuscular β2-agonist injections appear to have opposing effects on skeletal muscles. The present study has been designed to assess the effects of denervation of the masseter, intramuscular injection of a β2-agonist and the combination of both procedures, on bone density in the craniofacial skeleton in rats.

Published in Australasian Orthodontic Journal

ISSN: 2207-7480 (Online)
Publisher: Sciendo
Country of publisher: Poland
LCC subjects: Medicine: Dentistry
Website: https://sciendo.com/it/journal/AOJ

About the journal